A2A Pharmaceuticals, Inc. 4
4 · Biomea Fusion, Inc. · Filed Jun 2, 2023
Insider Transaction Report
Form 4
A2A Pharmaceuticals, Inc.
10% Owner
Transactions
- Sale
Common Stock
2023-06-01$34.56/sh−50,000$1,728,165→ 3,500,000 total - Sale
Common Stock
2023-05-31$33.81/sh−75,000$2,535,750→ 3,550,000 total
Footnotes (2)
- [F1]A total of 75,000 shares were sold at an average price of 33.81 in multiple transactions ranging from 33.44 to 34.43. Details of the specific transactions are available upon request.
- [F2]A total of 50,000 shares were sold at an average price of 34.5633 in multiple transactions ranging from 34.50 to 35.02 Details of the specific transactions are available upon request.